This compound is a chemical compound used as a pharmaceutical intermediate. Its primary significance is in the manufacturing process for osimertinib, an active pharmaceutical ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1421372-94-2
N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro-1,4-benzenediamine
pharmaceutical intermediate
4-Fluoro-2-methoxy-5-nitroaniline
pharmaceutical intermediate
2-Bromo-4-fluorotoluene
pharmaceutical intermediate
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol
pharmaceutical intermediate
(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol
pharmaceutical intermediate
(3R,4S)-3-FLUOROOXAN-4-OL
pharmaceutical intermediate
Mutated EGFR-IN-1
pharmaceutical raw material
N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amine
SZTYQQYYIMVETL-UHFFFAOYSA-N
CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=CC(=C(C=C4OC)F)[N+](=O)[O-]